Wall Street’s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

Park Hotels & Resorts Inc. (NYSE:PK)

  • Dividend Yield: 10.01%
  • Morgan Stanley analyst Stephen Grambling maintained an Equal-Weight rating and cut the price target from $12 to $10 on April 22, 2025. This analyst has an accuracy rate of 62%.
  • Truist Securities analyst Patrick Scholes maintained a Buy rating and slashed the price target from $18 to $16 on March 21, 2025. This analyst has an accuracy rate of 62%.
  • Recent News: Park Hotels & Resorts will release its financial results for the first quarter before the stock market opens on Monday, May 5.
  • Benzinga Pro’s real-time newsfeed alerted to latest PK news.

RLJ Lodging Trust (NYSE:RLJ)

  • Dividend Yield: 8.63%
  • Truist Securities analyst Gregory Miller downgraded the stock from Buy to Hold and cut the price target from $11 to $10 on March 21, 2025. This analyst has an accuracy rate of 66%.
  • Wolfe Research analyst Keegan Carl downgraded the stock from Outperform to Peer Perform on Sept. 26, 2024. This analyst has an accuracy rate of 61%.
  • Recent News: RLJ Lodging Trust will report financial results for the first quarter, before the markets open on May 5.
  • Benzinga Pro’s real-time newsfeed alerted to latest RLJ news

Healthcare Realty Trust Incorporated (NYSE:HR)

  • Dividend Yield: 7.88%
  • Wedbush analyst Richard Anderson downgraded the stock from Neutral to Underperform and cut the price target from $18 to $16 on Jan. 2, 2025. This analyst has an accuracy rate of 63%.
  • Wells Fargo analyst James Feldman assumed an Underweight rating and raised the price target from $16 to $17 on Oct. 1, 2024. This analyst has an accuracy rate of 61%.
  • Recent News: On April 7, Healthcare Realty named Healthpeak CFO Peter Scott as new CEO, succeeding interim Chief Connie Moore.
  • Benzinga Pro’s real-time newsfeed alerted to latest HR news

Read More:



Photo via Shutterstock



More Sponsored Headlines